Variant report
Variant | nsv889984 |
---|---|
Chromosome Location | chr8:5119564-5157363 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73659779 | chr8:5137409-5137410 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs114154117 | chr8:5137444-5137445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182921913 | chr8:5137455-5137456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs918150 | chr8:5137475-5137476 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187598557 | chr8:5137480-5137481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572594268 | chr8:5137511-5137512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549406490 | chr8:5137559-5137560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117460794 | chr8:5137585-5137586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142125168 | chr8:5137623-5137624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs199637130 | chr8:5137628-5137629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576498528 | chr8:5137630-5137631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190851749 | chr8:5137674-5137675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17072852 | chr8:5137681-5137682 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs529555288 | chr8:5137682-5137683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17436033 | chr8:5137707-5137708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143192541 | chr8:5137719-5137720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148280773 | chr8:5137721-5137722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184093494 | chr8:5137738-5137739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1420848 | chr8:5137748-5137749 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs117618991 | chr8:5137786-5137787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533996021 | chr8:5137792-5137793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553884000 | chr8:5137803-5137804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141335045 | chr8:5137805-5137806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7815410 | chr8:5137816-5137817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567466783 | chr8:5137822-5137823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534891080 | chr8:5137887-5137888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552919564 | chr8:5137891-5137892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73190993 | chr8:5137901-5137902 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs150730069 | chr8:5137905-5137906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs202056436 | chr8:5137907-5137908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575447019 | chr8:5137924-5137925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558282557 | chr8:5137946-5137947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576561551 | chr8:5138016-5138017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73507089 | chr8:5138081-5138082 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs188939469 | chr8:5138147-5138148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574277059 | chr8:5138179-5138180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544037397 | chr8:5138198-5138199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs137883334 | chr8:5138201-5138202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533345698 | chr8:5138202-5138203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544199988 | chr8:5138218-5138219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551512325 | chr8:5138251-5138252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs60878162 | chr8:5138259-5138260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563052748 | chr8:5138267-5138268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530594480 | chr8:5138285-5138286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548726065 | chr8:5138286-5138287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370938519 | chr8:5138301-5138302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534645971 | chr8:5138334-5138335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs61358520 | chr8:5138339-5138340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546909535 | chr8:5138341-5138342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564073439 | chr8:5138357-5138358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Medulloblastoma | 16783165 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5137400-5139600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr8:5137800-5140200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr8:5138200-5138400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:5138400-5138800 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr8:5138400-5138800 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr8:5138400-5138800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr8:5138400-5138800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr8:5138400-5139600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr8:5138800-5139000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr8:5138800-5139200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr8:5138800-5140600 | Weak transcription | H9 Cell Line | embryonic stem cell |
12 | chr8:5138800-5141800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
13 | chr8:5139200-5139800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr8:5139400-5139600 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr8:5140600-5140800 | Enhancers | H9 Cell Line | embryonic stem cell |
16 | chr8:5140800-5141200 | Weak transcription | H9 Cell Line | embryonic stem cell |
17 | chr8:5141800-5142000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr8:5148800-5150000 | Weak transcription | H9 Cell Line | embryonic stem cell |
19 | chr8:5149600-5150200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr8:5149800-5150400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
21 | chr8:5150000-5150200 | Enhancers | H9 Cell Line | embryonic stem cell |
22 | chr8:5150200-5157400 | Weak transcription | H9 Cell Line | embryonic stem cell |
23 | chr8:5154800-5155200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |